Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Ischemic Heart Disease

Free Subscription 27.04.2026 1 Am Heart J 10 Am J Cardiol 1 Am J Med 2 Angiology 1 Ann Thorac Surg 3 Arterioscler Thromb Vasc Biol 15 Atherosclerosis 2 Can J Cardiol 1 Catheter Cardiovasc Interv 1 Circ Cardiovasc Imaging 2 Circ Cardiovasc Interv 3 Circulation 3 Clin Cardiol 2 Eur Heart J 1 Hypertension 2 Int J Cardiol 5 J Am Coll Cardiol 1 J Clin Invest 2 J Mol Cell Cardiol 1 J Thorac Cardiovasc Surg 1 JAMA 8 N Engl J Med 1 Prog Cardiovasc Dis

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. SUSCHA C, Luterstein E, Tong N, Murphy S, et al
   Validity of international classification of diseases, tenth revision codes in diagnosing myocardial infarction subtypes.
   Am Heart J. 2026 Apr 19:107447. doi: 10.1016/j.ahj.2026.107447.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

2. LIM VZK, Chin CT, Chee FY, Lau YH, et al
   Comorbidity Burden and Length of Stay After Myocardial Infarction: A Retrospective Study Using Large Language Model-Assisted Chart Abstraction in a Tertiary Cardiac Hospital.
   Am J Cardiol. 2026 Apr 16:S0002-9149(26)00228.
   PubMed         Abstract available
   
   
3. NIKOO MZ, Kumar S, Maki MK, Krishnaswami A, et al
   The Economic Burden of Cardiovascular Disease in the United StatesAuthors.
   Am J Cardiol. 2026 Apr 20:S0002-9149(26)00249.
   PubMed         Abstract available
   
   
4. SAGOO R, Sagoo NS, Nguyen K, Sathyamoorthy M, et al
   Sex-Based Differences in Cardiovascular Diagnoses, Mortality, and Resource Utilization in Long COVID Hospitalizations: A National Inpatient Sample Analysis.
   Am J Cardiol. 2026 Apr 19:S0002-9149(26)00253.
   PubMed         Abstract available
   
   
5. ABDENNADHER B, Gossling A, Kellner C, Koschwitz J, et al
   Prognostic value of cardiovascular biomarkers for cardiac stress test results and adverse cardiovascular events in patients with suspected coronary artery disease.
   Am J Cardiol. 2026 Apr 19:S0002-9149(26)00232.
   PubMed         Abstract available
   
   
6. KUMAR PD
   Is Prasugrel a Better Antiplatelet Agent for Patients with Active Cancer and Coronary Artery Disease?
   Am J Cardiol. 2026 Apr 19:S0002-9149(26)00264.
   PubMed        
   
   
7. ZIMMERLI A, Buri J, Salihu A, Mahendiran T, et al
   Effect of State-of-the-Art Treatment on Symptoms, Absolute Coronary Artery Flow, and Resistance among patients with Ischemia and Non-Obstructive Coronary Arteries (STAR-INOCA Study): Study design and Rationale.
   Am J Cardiol. 2026 Apr 18:S0002-9149(26)00243.
   PubMed         Abstract available
   
   
8. BHASKAR S, Pirruccello J, Hoffmann TJ, Beatty A, et al
   The Role of Socioeconomic Status in the Association between Genetic Predisposition and Cardiovascular Events: A UK Biobank Study.
   Am J Cardiol. 2026 Apr 17:S0002-9149(26)00246.
   PubMed         Abstract available
   
   
9. CORVISIER MF, Ziotti SDV, Rodrigues LS, Santos LEB, et al
   Impact of Cancer on Early Outcomes After Coronary Artery Bypass Grafting According to Cancer Stage - A Systematic Review and Meta-Analysis.
   Am J Cardiol. 2026 Apr 17:S0002-9149(26)00234.
   PubMed         Abstract available
   
   
10. KURTUL A, Bekler O, Sagaltici E, Sen F, et al
    Fragmented QRS as a predictor of in-hospital major adverse cardiovascular events in patients undergoing transcatheter aortic valve implantation.
    Am J Cardiol. 2026 Apr 17:S0002-9149(26)00251.
    PubMed         Abstract available
    
    
11. MOON J, Jackevicius CA
    National Trends in Cardiovascular Disease Medication Dispensing Patterns During the COVID-19 Pandemic: Insights from the Department of Veterans Affairs.
    Am J Cardiol. 2026 Apr 16:S0002-9149(26)00252.
    PubMed        
    
    

    
    Am J Med

12. OU YH, Colpani JT, Cheong CS, Loke W, et al
    Treatment of OSA using mandibular advancement versus CPAP in improving cardiovascular health.
    Am J Med. 2026 Apr 19:S0002-9343(26)00293-7. doi: 10.1016/j.amjmed.2026.
    PubMed         Abstract available
    
    

    
    Angiology

13. LV X, Lv S, Zhou X
    Carotid Ultrasound for Predicting Vascular Cognitive Impairment in Cardiovascular Patients: A Retrospective Study.
    Angiology. 2026 Apr 19:33197261435395. doi: 10.1177/00033197261435395.
    PubMed         Abstract available
    
    
14. AGRAWAL A, Bhagat U, Sharma A, Nanda S, et al
    Predictors and Outcomes of Pulmonary Embolism After Coronary Artery Bypass Grafting.
    Angiology. 2026 Apr 19:33197261436916. doi: 10.1177/00033197261436916.
    PubMed         Abstract available
    
    

    
    Ann Thorac Surg

15. GARCIA-VILLARREAL OA
    Survival Outcomes of Combined Mitral Valve Surgery and Coronary Artery Bypass Grafting in Moderate Ischemic Mitral Regurgitation.
    Ann Thorac Surg. 2026 Apr 20:S0003-4975(26)00353.
    PubMed        
    
    

    
    Arterioscler Thromb Vasc Biol

16. INUI H, Yu X, Pfrender E, Bednarek J, et al
    Macrophage Efferocytosis in Heart.
    Arterioscler Thromb Vasc Biol. 2026;46:e323209.
    PubMed         Abstract available
    
    
17. LEE-KIM VS, Schnitzler GR, Fang S, Mardani-Kamali N, et al
    Common Coronary Artery Disease Risk Variants in Endothelial Regulatory Elements Modulate Tetraspanin 14 Expression and Notch Signaling.
    Arterioscler Thromb Vasc Biol. 2026 Apr 23. doi: 10.1161/ATVBAHA.125.323330.
    PubMed         Abstract available
    
    
18. QIAN F, Gajjar P, Prescott B, Mitchell GF, et al
    Modifiable Correlates With Systemic Thromboxane Generation and Association With Cardiovascular Outcomes: Results From the Framingham Heart Study.
    Arterioscler Thromb Vasc Biol. 2026 Apr 23. doi: 10.1161/ATVBAHA.126.324561.
    PubMed         Abstract available
    
    

    
    Atherosclerosis

19. KIM M, Lee HA, Kim J, Kang HT, et al
    Metabolic dysfunction-associated steatotic liver disease and incident coronary events with revascularization: A nationwide cohort study.
    Atherosclerosis. 2026;415:120698.
    PubMed         Abstract available
    
    
20. BEDNAREK A, Serruys PW, Tsai TY, Gumiezna K, et al
    Impact of coronary artery disease patterns assessed with pullback pressure gradient on clinical outcomes: Meta-analysis.
    Atherosclerosis. 2026;415:120688.
    PubMed         Abstract available
    
    
21. SEBASTIAN SA, Bimal T, Ayyalu T, Vartak N, et al
    Association of Lp(a) with coronary plaque burden and high-risk plaque features: A meta-analysis of imaging studies.
    Atherosclerosis. 2026;415:120706.
    PubMed         Abstract available
    
    
22. ODDEN MC, Liu X, Shah AM, Yang Y, et al
    Proteomic pathways mediating low socioeconomic status and cardiovascular events in older adults in CHS and ARIC.
    Atherosclerosis. 2026;415:120705.
    PubMed         Abstract available
    
    
23. ZABEN KJ, Khalil AA
    Health literacy and quality of life after acute coronary syndrome: the mediating role of self-care in Palestine.
    Atherosclerosis. 2026;415:120671.
    PubMed         Abstract available
    
    
24. POON EKW, Shishikura D, Silver JD, Hatzikostas L, et al
    Haemodynamic and blood viscosity profiles of culprit vs. non-culprit coronary vessels: Insights from NIRS-IVUS and CFD analysis.
    Atherosclerosis. 2026;415:120690.
    PubMed         Abstract available
    
    
25. RUIDAS B, Michaud WA, Lindner SR, Tessier SN, et al
    Improving cardiac resilience to ischemia/reperfusion: The role of butyrate in mitochondrial and metabolic recovery.
    Atherosclerosis. 2026;415:120669.
    PubMed         Abstract available
    
    
26. SELEME VB, da Silva Costa IBS, Pileggi B, de Barros Branco CE, et al
    Association of cancer on coronary atherosclerotic burden and plaque rupture: Insights from the BRAVADO study.
    Atherosclerosis. 2026;415:120683.
    PubMed         Abstract available
    
    
27. OTERINO A, Fernandez Olmo R, Martin Toro M, Cordero A, et al
    Intensive lipid-lowering strategies and major cardiovascular events in patients aged >/=65 years: A meta-analysis of randomized trial subgroups.
    Atherosclerosis. 2026;415:120714.
    PubMed         Abstract available
    
    
28. SCHONCK WA, Hovingh GK, Blom DJ, Tromp T, et al
    Traditional cardiovascular risk factors and their association with atherosclerotic cardiovascular disease in homozygous familial hypercholesterolemia: A cross-sectional analysis from the HICC registry.
    Atherosclerosis. 2026;415:120717.
    PubMed         Abstract available
    
    
29. KATAOKA Y, Nicholls SJ, Kitahara S, Katasako-Yabumoto A, et al
    Achieving LDL-C <1.0 mmol/L and cardiovascular outcomes in patients with coronary artery disease who received percutaneous coronary intervention.
    Atherosclerosis. 2026;415:120684.
    PubMed         Abstract available
    
    
30. DAGHLAS I, Georgakis MK, Brennan SO, Arsenault BJ, et al
    Genetically proxied IL-6 signaling inhibition, lipoprotein(a) levels, and atherosclerotic disease risk.
    Atherosclerosis. 2026;415:120723.
    PubMed         Abstract available
    
    
31. EMANUELE E, Barth JD
    The persistent challenge of medication adherence after myocardial infarction in the real-world: Why compliance keeps taking the hit.
    Atherosclerosis. 2026;415:120695.
    PubMed        
    
    
32. ZHOU J, Guo X, Gao W, Xia Y, et al
    Evolocumab in patients with multivessel coronary disease after acute myocardial infarction: A target trial emulation.
    Atherosclerosis. 2026;416:120732.
    PubMed         Abstract available
    
    
33. HALMOS B, Salzbrunn JB, van Zeventer IA, de Graaf AO, et al
    DNMT3A clonal hematopoiesis is associated with cardiovascular disease in women.
    Atherosclerosis. 2026;415:120722.
    PubMed         Abstract available
    
    

    
    Can J Cardiol

34. SUBHERWAL NG, Subherwal SP, Kim J, Sternfeld D, et al
    A Unique Case of Methemoglobinemia Presenting With ST Elevation Myocardial Infarction, Shock, and Left Ventricular Dysfunction.
    Can J Cardiol. 2026 Apr 20:S0828-282X(26)00359.
    PubMed        
    
    
35. DI GIOIA G, Ferrone M, Franco D, Russo M, et al
    Clinical outcomes of Sirolimus coated balloons for the treatment of coronary disease. The Metal-Free registry.
    Can J Cardiol. 2026 Apr 21:S0828-282X(26)00363.
    PubMed         Abstract available
    
    

    
    Catheter Cardiovasc Interv

36. POPOVIC B, Djaballah N, Tomic M, Fay R, et al
    Influence of the Residual Gensini Score on Prognosis of Patients With ST-Elevation Myocardial Infarction.
    Catheter Cardiovasc Interv. 2026 Apr 21. doi: 10.1002/ccd.70633.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Imaging

37. RAMIREZ G, Builoff V, Miller RJH, Lemley M, et al
    Multicenter Evaluation of Myocardial Flow Reserve as a Prognostic Marker for Mortality in (13)N-Ammonia PET Myocardial Perfusion Imaging.
    Circ Cardiovasc Imaging. 2026 Jan 30:e018729.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Interv

38. ZHOU J, Zhang Q, Lu H, Wu Y, et al
    Ultra-Low-Dose Noise-Free Technology to Reduce Radiation Exposure During Coronary Angiography.
    Circ Cardiovasc Interv. 2026 Apr 21:e016542.
    PubMed         Abstract available
    
    
39. YABUMOTO N, Fujino M, Kiyoshige E, Sugane H, et al
    Enhanced Efficacy of Rotational Atherectomy for Calcified Nodules With Contralateral Calcification: Insights From a Multicenter Intravascular Ultrasound Imaging Study.
    Circ Cardiovasc Interv. 2026 Feb 11:e015932.
    PubMed         Abstract available
    
    

    
    Circulation

40. LUO Y, Zhao J, Dong Q
    Letter by Luo et al Regarding Article, "Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults".
    Circulation. 2026;153:e1126-e1127.
    PubMed        
    
    
41. MORI Y, Sawano M, Kohsaka S, Tsugawa Y, et al
    Response by Mori et al to Letter Regarding Article, "Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults".
    Circulation. 2026;153:e1128-e1129.
    PubMed        
    
    
42. ZHANG B, Sun A, Ge J
    Intracellular TRPM7-Mediated Zn(2+) Release: A Novel Pyroptotic Axis in Myocardial Ischemia-Reperfusion Injury.
    Circulation. 2026;153:1230-1232.
    PubMed        
    
    

    
    Clin Cardiol

43. DIAZ JS, Anorga JL, Lopez L, Vera C, et al
    AsistIAM: Innovating the Acute Coronary Syndrome Approach in Primary Care Settings.
    Clin Cardiol. 2026;49:e70313.
    PubMed         Abstract available
    
    
44. WANG YJ, Li JM, Wu X, Liu T, et al
    Sex-Specific Associations With Abnormal Myocardial Flow Reserve in Non-Obstructive Coronary Artery Disease: Insights From a Real-World Cadmium-Zinc-Telluride SPECT Study.
    Clin Cardiol. 2026;49:e70294.
    PubMed         Abstract available
    
    
45. WU F, Zheng X, Hong L, Wu Q, et al
    The Potential Role of Baseline FT3/FT4 Ratio as a Prognostic Biomarker for Patients With Ischemic Non-Obstructive Coronary Artery Disease.
    Clin Cardiol. 2026;49:e70331.
    PubMed         Abstract available
    
    

    
    Eur Heart J

46. NURMOHAMED NS, Bhatt DL
    Bridging the gap in prevention of first myocardial infarction.
    Eur Heart J. 2026 Apr 24:ehag284. doi: 10.1093.
    PubMed        
    
    
47. SIMEON MJ
    Gaps in cardiovascular risk identification and preventive therapy before first myocardial infarction.
    Eur Heart J. 2026 Apr 24:ehag283. doi: 10.1093.
    PubMed        
    
    

    
    Hypertension

48. ZHANG Y, Guo S, Ma Y, Chen W, et al
    Association Between Cardiovascular Polygenic Risk and White Matter Hyperintensities: An Observational Study From the UK Biobank.
    Hypertension. 2026 Apr 22. doi: 10.1161/HYPERTENSIONAHA.125.26388.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

49. YUAN W, Guo Y, Xu R
    Editorial to "Radiomics with native T1 mapping for contrast-free detection of acute and chronic myocardial infarction: A multicenter study".
    Int J Cardiol. 2026 Apr 20:134501. doi: 10.1016/j.ijcard.2026.134501.
    PubMed        
    
    
50. LARA-GONZALEZ M, Munoz P, Pedraz-Prieto A, Delgado-Montero A, et al
    Prognostic impact of previous and new myocardial infarction in patients with infective endocarditis.
    Int J Cardiol. 2026;456:134508.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

51. KAPUR NK, Mangner N, Aghili N, Faraz H, et al
    Left Ventricular Unloading in Anterior ST-Segment Elevation Myocardial Infarction Without Shock: The ST-Segment Elevation Myocardial Infarction Door to Unload Randomized Controlled Trial.
    J Am Coll Cardiol. 2026 Mar 28:S0735-1097(26)05923.
    PubMed         Abstract available
    
    
52. NAKASUKA K, Kewcharoen J, Salazar JW, Connolly AJ, et al
    Sudden Cardiac Death Due to Myocardial Infarction With Obstructive and Nonobstructive Coronary Arteries.
    J Am Coll Cardiol. 2026 Mar 23:S0735-1097(26)00140.
    PubMed         Abstract available
    
    
53. CHIEW K, Foley MJ, Chotai S, Naderi Z, et al
    Focal and Diffuse Coronary Artery Disease Patterns and Placebo-Controlled Angina Relief With Percutaneous Coronary Intervention: ORBITA-2.
    J Am Coll Cardiol. 2026 Apr 22:S0735-1097(26)05732.
    PubMed         Abstract available
    
    
54. HAMID A, Raggi P, Lipardi C, Borentain M, et al
    Cardiovascular Trials in Hemodialysis: Closing the Evidence Gap.
    J Am Coll Cardiol. 2026;87:1986-2005.
    PubMed         Abstract available
    
    
55. KHAN S, Sajjad U, Fawaz S, Butt H, et al
    Randomized, Placebo-Controlled Trial of Chronic Total Occlusion Percutaneous Coronary Intervention in Stable Angina: The ORBITA-CTO Trial.
    J Am Coll Cardiol. 2026 Mar 29:S0735-1097(26)05745.
    PubMed         Abstract available
    
    

    
    J Clin Invest

56. GOONEWARDENA SN, Yao S, Jurga T, Zhang L, et al
    Lipoprotein(a)-Associated Proteomic Signature Predicts Cardiovascular Disease in Young Adults.
    J Clin Invest. 2026 Apr 16:e204287. doi: 10.1172/JCI204287.
    PubMed         Abstract available
    
    

    
    J Mol Cell Cardiol

57. ZHOU H, Christopher CJ, Jones K, Pla MM, et al
    Myocardial metabolic remodeling in human end-stage ischemic and non-ischemic cardiomyopathy.
    J Mol Cell Cardiol. 2026;214:17-27.
    PubMed         Abstract available
    
    
58. ROMAN B, Petersen CE, Sun J, Murphy E, et al
    Sex differences in mitochondrial Ca(2+) during ischemia/reperfusion injury: A role for S-Nitrosylation.
    J Mol Cell Cardiol. 2026;214:1-10.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

59. CRESTANELLO JA, Sawma T, Arghami A
    Reply: From risk marker to decision support: Artificial intelligence electrocardiogram age in coronary artery bypass grafting.
    J Thorac Cardiovasc Surg. 2026 Apr 22:S0022-5223(26)00841.
    PubMed        
    
    

    
    JAMA

60. BOND RM, Debbink MP, Geller A, Lieu TA, et al
    Preventing Pregnancy-Related Cardiovascular Disease Burden: A Report From the National Academies of Sciences, Engineering, and Medicine.
    JAMA. 2026 Apr 21. doi: 10.1001/jama.2026.6717.
    PubMed        
    
    

    
    N Engl J Med

61. IBANEZ B, Jernberg T, Atar D
    Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction. Reply.
    N Engl J Med. 2026;394:1660-1661.
    PubMed        
    
    
62. OMEROVIC E
    Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction.
    N Engl J Med. 2026;394:1660.
    PubMed        
    
    
63. TURGEON R
    Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction.
    N Engl J Med. 2026;394:1659-1660.
    PubMed        
    
    
64. BOHULA EA, Giugliano RP, Sabatine MS
    Evolocumab for Primary Prevention of Cardiovascular Disease. Reply.
    N Engl J Med. 2026;394:1658-1659.
    PubMed        
    
    
65. BUDOFF MJ, Iskander B
    Evolocumab for Primary Prevention of Cardiovascular Disease.
    N Engl J Med. 2026;394:1658.
    PubMed        
    
    
66. GARCIA DE TENA J, Morales-Ortega A, Bernal-Bello D
    Evolocumab for Primary Prevention of Cardiovascular Disease.
    N Engl J Med. 2026;394:1658.
    PubMed        
    
    
67. KJELDSEN SE, Kreutz R, Mancia G
    Evolocumab for Primary Prevention of Cardiovascular Disease.
    N Engl J Med. 2026;394:1657-1658.
    PubMed        
    
    
68. PIRIS GONZALEZ M, Ortiz A
    Evolocumab for Primary Prevention of Cardiovascular Disease.
    N Engl J Med. 2026;394:1656-1657.
    PubMed        
    
    

    
    Prog Cardiovasc Dis

69. CIPOLLETTA E, Moroncini G
    Gout as a cardiovascular risk factor: Implications beyond the joint.
    Prog Cardiovasc Dis. 2026 Apr 21:S0033-0620(26)00036.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum